Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MEDTRONIC'S BRADYCARDIA PACERS HELP PUSH SECOND QUARTER SALES TO $408.2 MIL.

This article was originally published in The Gray Sheet

Executive Summary

MEDTRONIC'S BRADYCARDIA PACERS HELP PUSH SECOND QUARTER SALES TO $408.2 MIL., a 22.9% gain for the quarter (ended Oct. 28) over the same period a year ago. Bradycardia unit sales were higher than during "any quarter in the company's history," the firm said, adding that pacemaker results were aided by the performance of the Thera line and model 9790 programmer in European markets. The Thera devices were commercially released on Nov. 1 in Japan and Canada and are under study in the U.S.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003106

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel